Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Wednesday, May 1, 2013 - 09:23, By: Amy Madsen
Name: Tirasemtiv (CK-2017357)
How it works: Tirasemtiv, developed by Cytokinetics, is designed to increase the sensitivity of muscle fibers to calcium, resulting in a potential increase in muscle force generation.
CK-2017357 is being tested in combination with riluzole; Neuralstem is testing its stem cells in the cervical region of the spinal cord
Posted on Thursday, November 10, 2011 - 15:43, By: Amy Madsen
Editor's note 3/19/12: This story has been updated to reflect that Neuralstem has begun testing its stem cells in the cervical (neck) region of the spinal cord.
Two human clinical trials to test therapies in amyotrophic lateral sclerosis (ALS) are moving forward.
Posted on Saturday, May 1, 2010 - 12:57, By: ALSN Staff
An MDA-supported, 10-center trial of 108 people with ALS who took the oral medication lithium carbonate — some in conjunction with the ALS drug riluzole — has found the drug does not slow ALS progression or improve survival time. The study has also shown that lithium, which is used to treat bipolar...
Posted on Sunday, June 1, 2008 - 09:16, By: Other
MDA-funded lithium trial is now open
Posted on Saturday, March 1, 2008 - 13:37, By: Margaret Wahl
MDA to fast-track lithium trial